Emmessar Biotech reappoints MD and WTD at 34th AGM
- Emmessar Biotech & Nutrition Limited held its 34th AGM on September 29, 2026, via video conferencing
- Special resolutions approved the five-year re-appointment of Srinivasa Raghavan Mathurakavi Ayyangar as Managing Director
- Jeyavel Balaiah Nadar was re-appointed as Whole Time Director for a further period of five years
- Remote e-voting results are expected to be announced within 48 hours of the scrutinizer's report

*this image is generated using AI for illustrative purposes only.
Emmessar Biotech & Nutrition Limited concluded its 34th Annual General Meeting on September 29, 2026, with members approving key leadership appointments. The meeting was conducted through Video Conferencing and Other Audio Visual Means, ensuring continuity in corporate governance protocols.
The shareholders passed special resolutions to re-appoint Srinivasa Raghavan Mathurakavi Ayyangar as Managing Director and Jeyavel Balaiah Nadar as Whole Time Director for a further period of five years. Additionally, Nadar was re-appointed as a Director retiring by rotation under an ordinary resolution.
Governance and voting procedures
The meeting commenced at 10:30 am with Srinivasa Raghavan Mathurakavi Ayyangar elected as Chairman. The requisite quorum was present, allowing the Chairman to call the meeting to order. The Company Secretary briefed members on procedural aspects, and the Notice of the Meeting was taken as read with member permission.
Remote e-voting facilities were provided by MUFG Intime India Private Limited (formerly Linkintime India Private Limited). The voting window opened at 9:00 am on September 26, 2026, and closed at 5:00 pm on September 28, 2026. During the live meeting, e-voting remained open for 15 minutes after the formal closure to allow participating members to cast their votes.
Resolutions transacted
The following business items were transacted during the annual general meeting:
| Item No | Particulars | Resolution Type |
|---|---|---|
| 1 | Adoption of Audited Financial Statements for FY26 along with Board and Auditor reports | Ordinary |
| 2 | Re-appointment of Jeyavel Balaiah Nadar (DIN: 08163899) as Director | Ordinary |
| 3 | Re-appointment of Srinivasa Raghavan Mathurakavi Ayyangar (DIN: 00090266) as Managing Director for 5 years | Special |
| 4 | Re-appointment of Jeyavel Balaiah Nadar (DIN: 08163899) as Whole Time Director for 5 years | Special |
Tribhuwneshwar B. Kaushik, or in his absence Savyasachi Joshi, from Kaushik Joshi & Co., served as scrutinizers. The results of the remote e-voting and on-site e-voting are scheduled for announcement within 48 hours of receiving the scrutinizer's report. The meeting officially concluded at 10:56 am.
Historical Stock Returns for Emmessar Biotech
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +5.74% | -0.08% | -4.16% | -0.29% | -29.46% | -28.29% |
How will the five-year continuity of the current leadership team influence Emmessar Biotech's strategic direction regarding R&D investments and market expansion?
What specific operational milestones or financial targets has the re-appointed Managing Director outlined for the upcoming fiscal years to justify the extended tenure?
How might the stable governance structure impact institutional investor confidence and the company's valuation in the near-term biotech sector?

































